MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Novel GBA risk factor gene mutation p.W378R in a kindred with Gaucher’s disease and Parkinson’s disease

M. Lubomski, M. Hayes, M. Kennerson, M. Ellis, S. Chu, J. Blackie, J. O’Sullivan, G. Nicholson (Sydney, Australia)

Meeting: 2018 International Congress

Abstract Number: 1298

Keywords: Familial neurodegenerative diseases, Gait disorders: Genetics, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: We undertook mutation analysis of the Glucocerebrosidase gene (GBA) gene in a large three-generational Australian kindred consisting of some individuals with both type 1 Gaucher’s disease (GD) with and without Parkinson’s disease (PD) as well as others with PD alone.

Background: GBA mutations, initially recognised as the cause of GD, are now established as the most important genetic risk factor for developing PD. Lysosomal GBA enzymatic deficiency impairs α-synuclein clearance. Although more than 300 GBA mutations have been described, pathogenic mutations are most likely to be found in rare families with individuals manifesting both GD and PD. Heterozygous mutations in GBA may be present in 4-28% of patients with PD, with many patients manifesting symptoms in their forties, often clinically indistinguishable from sporadic PD aside from accelerated cognitive impairment.

Methods: A combination of whole exome sequencing and exon Sanger sequencing was used to validate novel variants and test for segregation in the family.

Results: A novel missense heterozygous mutation in the GBA gene, p.W378R in exon 9 was identified in the kindred segregated in five affected members: two individuals with a heterozygous W378R allele conferring PD risk; three had a compound heterozygous W378R/N370S alleles (two with PD-GD and one with only GD). Six of ten variant carriers developed PD, a penetrance of 60%. One elderly individual with a heterozygous W378R allele was asymptomatic but had mild extra-pyramidal features suggestive of PD.

Conclusions: We have identified a novel pathogenic variant in the GBA gene (W378R), which has a high penetrance and could confer both type 1 GD (when compound heterozygous with the common GD mutation N370S) and PD in the heterozygous state in six of ten variant carriers. These results show that the W378R mutation in GBA is likely to be a pathogenic allele contributing to GD and is a strong risk factor for PD. Early recognition of such PD-GBA mutations may enable timely access to new preventative therapies for PD, some of which have commenced therapeutic trials.

To cite this abstract in AMA style:

M. Lubomski, M. Hayes, M. Kennerson, M. Ellis, S. Chu, J. Blackie, J. O’Sullivan, G. Nicholson. Novel GBA risk factor gene mutation p.W378R in a kindred with Gaucher’s disease and Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/novel-gba-risk-factor-gene-mutation-p-w378r-in-a-kindred-with-gauchers-disease-and-parkinsons-disease/. Accessed May 24, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/novel-gba-risk-factor-gene-mutation-p-w378r-in-a-kindred-with-gauchers-disease-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley